Dynavax Technologies Corporation news

   Watch this stock
Showing stories 11 - 20 of about 88   

Articles published

DVAX 22.05 +0.31 (1.43%)
price chart
Stock Runners: Dynavax Technologies Corporation (NASDAQ:DVAX), Transition ...
Dynavax Technologies Corporation (NASDAQ:DVAX) belongs to Healthcare sector. Its weekly performance is -2.73%. On last trading day company shares ended up $19.95.
Dynavax Technologies Corp first-quarter loss widens  Myiris.com
Stock in Motion: Dynavax Technologies Corporation (NASDAQ:DVAX)
Dynavax Technologies Corporation (NASDAQ:DVAX) shares opened the most recent trading session at 19.98 and at the time of writing the last Bid was at 19.95.
Dynavax Technologies Lowered to "Hold" at Zacks (DVAX)  The Legacy
Why Need to Watch: Dynavax Technologies Corporation (NASDAQ:DVAX ...
Dynavax Technologies Corporation (NASDAQ:DVAX) belongs to Healthcare sector. Its weekly performance is 4.79%. On last trading day company shares ended up $21.00.
Here is What Hedge Funds Think About Dynavax Technologies Corporation ...
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age. Although there are over 8,000 hedge funds in operation in present day, this site focuses on the leaders of this group, about 525 funds.
Related articles »  
Analysts Give Average Rating of "Strong Buy" to Dynavax Technologies ...
Dynavax Technologies logo Shares of Dynavax Technologies (NASDAQ:DVAX) have been given an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports.
Hedge Funds Are Crazy About Dynavax Technologies Corporation (DVAX)
Dynavax Technologies Corporation To the average investor, there are dozens of gauges shareholders can use to track publicly traded companies.
Dynavax: FDA Asks For Additional Safety Data  Seeking Alpha
Dynavax's hepatitis B vaccine delayed as FDA seeks more data  Reuters
Related articles »  
DynaVax Technologies: The Small Cap Gem Focus Stock Of The Week (DVAX)
Their technology looks to inhibit Toll-like Receptors (TLRs). TLRs are key receptors of the innate immune system that can induce strong inflammatory responses.
Dynavax Technologies Corporation (DVAX) news: Dynavax: An Update On This ...
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
Dynavax Receives Milestone Payments from AstraZeneca  Zacks.com
Related articles »  
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Dynavax ...
... LLP (www.rmclasslaw.com/cases/dvax) announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of purchasers of Dynavax Technologies Corporation ("Dynavax" or the ...
Related articles »  
Dynavax Technologies accesses $40 mln credit facility from Hercules
Hercules Technology Growth Capital, Inc has provided up to $40 million in a credit facility to Dynavax Technologies Corporation, a clinical-stage biotechnology company. Dynavax drew $10 million upon closing and has access to an additional $30 million ...